Corner Office
Oxford University Has a Shot at Vaccine Billions. Or Does It?
Illustration by II
Inside the competitive, turbulent, and morally fraught race to capitalize on a Covid-19 vaccine.
By
Amy Whyte
September 23, 2020
Pittsburgh School
Pfizer
U.K.
AstraZeneca
Harding Loevner
